Investors

Fresenius Medical Care, the world’s largest provider of dialysis products and services, today released the following statement in response to the defeat of the ballot initiative Proposition 8 in California.

Patient growth continues across all regions Operating margin in North America improved to 18.5% in the third quarter Dialysis Care revenue growth in North America of 6% (+5% at constant currency)

Anticipated revenue decrease of around 6% on a reported basis and an increase of around 2% on a comparable basis (+3% at constant currency)